Advisory Services Network’s Axsome Therapeutics AXSM Stock Holding History

Advisory Services Network’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-325	Closed	-$54.9K	–	2363
2026 Q1	$54.9K	Buy	+325	New	+$56.1K	﹤0.01%	2565
2025 Q4	–	Sell	-330	Closed	-$40.1K	–	2003
2025 Q3	$40.1K	Buy	+330	New	+$37.2K	﹤0.01%	2565
2024 Q1	–	Sell	-770	Closed	-$61.3K	–	1627
2023 Q4	$61.3K	Buy	+770	New	+$51.5K	﹤0.01%	1900
2023 Q2	–	Sell	-1,333	Closed	-$82.2K	–	1618
2023 Q1	$82.2K	Sell	1,333 -75	-5%	-$4.93K	﹤0.01%	1753
2022 Q4	$109K	Buy	+1,408	New	+$84.2K	﹤0.01%	1562
2021 Q3	–	Sell	-725	Closed	-$49K	–	1538
2021 Q2	$49K	Buy	+725	New	+$43.5K	﹤0.01%	2008
2021 Q1	–	Sell	-725	Closed	-$59K	–	1411
2020 Q4	$59K	Buy	725 +350	+93%	+$26.2K	﹤0.01%	1573
2020 Q3	$27K	Buy	+375	New	+$29.2K	﹤0.01%	1919

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Advisory Services Network's AXSM Position: Q2 2026 in Review

Advisory Services Network sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 325 shares — an estimated $54.9K sold.

Advisory Services Network first reported a position in AXSM in Q3 2020 and held it in 8 quarters. The position peaked at $109K in Q4 2022. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Advisory Services Network reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 325 Axsome Therapeutics shares in Q2 2026, an estimated $54.9K.
Advisory Services Network first reported a position in Axsome Therapeutics in Q3 2020 and held it in 8 quarters.
Advisory Services Network's Axsome Therapeutics position peaked at $109K in Q4 2022.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.